Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week
After the late Rep. Elijah Cummings launched a drug pricing probe of some of the industry’s largest players last January, six pharmaceutical execs are set to head to Washington next week for hearings at the House Committee on Oversight and Reform. Current and former executives from Celgene, Bristol Myers Squibb, Teva, Amgen, Mallinckrodt and Novartis will testify next Wednesday… Read More »
